Cantor Fitzgerald, L. P. »

Compass Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2024-09-30 $331k 180k 1.84

More positions owned by Cantor Fitzgerald, L. P.

Spdr S&p 500 Etf Tr Put Put Option
Nvidia Corporation Put Put Option
Tesla Put Put Option
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Call Call Option
Tesla Motors (TSLA)
Nvidia Corporation Call Call Option
Gcm Grosvenor Com Cl A (GCMG)
Rumble Com Cl A (RUM)
Tesla Call Call Option
Proshares Tr Ultrapro Qqq (TQQQ)
Super Micro Computer Put Put Option
Broadcom Put Put Option
Super Micro Computer (SMCI)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Compass Therapeutics

OrbiMed Advisors
Blackstone Group
BlackRock
BlackRock
Rock Springs Capital Management
Henderson Group
MPM Oncology Impact Management
Vanguard Group
Blue Owl Capital Holdings
Geode Capital Management
Cormorant Asset Management
State Street Corporation
Tang Capital Management
Baker Bros. Advisors
Northern Trust

View all funds holding Compass Therapeutics